Botanical species · safety record

Lamprocapnos spectabilis

The EFSA Compendium of Botanicals holds 8 constituent measurements for Lamprocapnos spectabilis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lamprocapnos spectabilis (L.) Fukuhara

8Constituent measurements

0Safety records

4Cited sources

0Licensed products (Canada)

Also recorded as

Dicentra spectabilis (L.) Lem.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Aerial part of plants	Solvent extraction	0.17 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Alkaloids	Roots and other underground parts	Solvent extraction	0.25 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Benzofurans	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Protopine	Live plants	Solvent extraction	≤ 11908 Microgram/gram	UHPLC-MS-MS	Resolve DOI
Protopine	Live plants	Solvent extraction	≥ 11890 Microgram/gram	UHPLC-MS-MS	Resolve DOI
Sanguinarine	Live plants	Solvent extraction	≤ 1106.6 Microgram/gram	UHPLC-MS-MS	Resolve DOI
Sanguinarine	Live plants	Solvent extraction	≥ 1104.6 Microgram/gram	UHPLC-MS-MS	Resolve DOI
P-coumaric acid	Aerial part of plants	Solvent extraction	0.12 Percent	HPLC-DAD	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Och, Anna., Szewczyk, Katarzyna., Pecio, Lukasz., Stochmal, Anna., Zaluski, Daniel., Bogucka-Kocka, Anna. UPLC-MS/MS Profile of Alkaloids with Cytotoxic Properties of Selected Medicinal Plants of the Berberidaceae and Papaveraceae Families. . Oxidative medicine and cellular longevity, 2017, vol. 2017, p. 9369872-9369872. DOI
BOEGGE, SC., NAHRSTEDT, A., LINSCHEID, M., NIGGE, W. DISTRIBUTION AND STEREOCHEMISTRY OF HYDROXYCINNAMOYLMALIC ACIDS AND OF FREE MALIC-ACIDS IN PAPAVERACEAE AND FUMARIACEAE . Zeitschrift fur naturforschung c-a journal of biosciences, 1995, vol. 50, no. 9-10, p. 608-615.
Israilov, I.A., Melikov, F.M., Murav'eva, D.A. Alkaloids of Dicentra. Chemistry of natural compounds, 1984, vol. 20, no. 1, p. 74-76. DOI
McNulty, James., Poloczek, Joanna., Larichev, Vladimir., Werstiuk, Nick H., Griffin, Carly., Pandey, Siyaram. Discovery of the apoptosis-inducing activity and high accumulation of the butenolides, menisdaurilide and aquilegiolide, in Dicentra spectabilis . Planta medica, 2007, vol. 73, no. 15, p. 1543-1547. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature